ELUT saw its Momentum Indicator move above the 0 level on November 09, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 110 similar instances where the indicator turned positive. In 99 of the 110 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
The Moving Average Convergence Divergence (MACD) for ELUT just turned positive on November 09, 2026. Looking at past instances where ELUT's MACD turned positive, the stock continued to rise in 48 of 55 cases over the following month. The odds of a continued upward trend are 87%.
ELUT moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ELUT crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
Following a +5.25% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELUT advanced for three days, in 199 of 228 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
The Aroon Indicator entered an Uptrend today. In 138 of 155 cases where ELUT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 89%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELUT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
ELUT broke above its upper Bollinger Band on November 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.355) is normal, around the industry mean (4.142). P/E Ratio (0.654) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (3.028) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. ELUT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELUT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
HSDT saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In 74 of the 80 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
HSDT moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HSDT crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSDT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for HSDT entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where HSDT advanced for three days, in 171 of 205 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
HSDT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. HSDT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.688) is normal, around the industry mean (2.412). P/E Ratio (0.010) is within average values for comparable stocks, (-2.386). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). Dividend Yield (0.000) settles around the average of (0.270) among similar stocks. P/S Ratio (11.574) is also within normal values, averaging (15.694).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
ELUT | HSDT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 83 | 79 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 48 Fair valued | 82 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 99 | |
PRICE GROWTH RATING 1..100 | 58 | 63 | |
P/E GROWTH RATING 1..100 | 58 | 7 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ELUT's Valuation (48) in the null industry is somewhat better than the same rating for HSDT (82) in the Medical Specialties industry. This means that ELUT’s stock grew somewhat faster than HSDT’s over the last 12 months.
ELUT's Profit vs Risk Rating (100) in the null industry is in the same range as HSDT (100) in the Medical Specialties industry. This means that ELUT’s stock grew similarly to HSDT’s over the last 12 months.
HSDT's SMR Rating (99) in the Medical Specialties industry is in the same range as ELUT (100) in the null industry. This means that HSDT’s stock grew similarly to ELUT’s over the last 12 months.
ELUT's Price Growth Rating (58) in the null industry is in the same range as HSDT (63) in the Medical Specialties industry. This means that ELUT’s stock grew similarly to HSDT’s over the last 12 months.
HSDT's P/E Growth Rating (7) in the Medical Specialties industry is somewhat better than the same rating for ELUT (58) in the null industry. This means that HSDT’s stock grew somewhat faster than ELUT’s over the last 12 months.
| ELUT | HSDT | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 85% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 82% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 87% | N/A |
| TrendWeek ODDS (%) | 2 days ago 87% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 87% | 2 days ago 90% |
| Advances ODDS (%) | 15 days ago 87% | 8 days ago 83% |
| Declines ODDS (%) | 7 days ago 88% | 2 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 81% |
| Aroon ODDS (%) | 2 days ago 89% | 2 days ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ELUT’s FA Score shows that 0 FA rating(s) are green while HSDT’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ELUT’s TA Score shows that 6 TA indicator(s) are bullish while HSDT’s TA Score has 4 bullish TA indicator(s).
ELUT (@Medical/Nursing Services) experienced а +14.72% price change this week, while HSDT (@Investment Managers) price change was -11.41% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.
The average weekly price growth across all stocks in the @Investment Managers industry was -2.64%. For the same industry, the average monthly price growth was -2.86%, and the average quarterly price growth was -1.76%.
ELUT is expected to report earnings on Mar 03, 2027.
HSDT is expected to report earnings on Nov 11, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Investment Managers (-2.64% weekly)Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
A.I.dvisor tells us that ELUT and XAIR have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELUT and XAIR's prices will move in lockstep.
| Ticker / NAME | Correlation To ELUT | 1D Price Change % | ||
|---|---|---|---|---|
| ELUT | 100% | +11.60% | ||
| XAIR - ELUT | 28% Poorly correlated | +8.62% | ||
| STRRP - ELUT | 23% Poorly correlated | +0.89% | ||
| STRR - ELUT | 23% Poorly correlated | -2.44% | ||
| HSDT - ELUT | 23% Poorly correlated | -4.95% | ||
| RPID - ELUT | 23% Poorly correlated | +3.21% | ||
More | ||||
A.I.dvisor indicates that over the last year, HSDT has been closely correlated with FWDI. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if HSDT jumps, then FWDI could also see price increases.
| Ticker / NAME | Correlation To HSDT | 1D Price Change % | ||
|---|---|---|---|---|
| HSDT | 100% | -4.95% | ||
| FWDI - HSDT | 66% Closely correlated | -5.24% | ||
| DFDV - HSDT | 62% Loosely correlated | -5.83% | ||
| ASST - HSDT | 60% Loosely correlated | +0.42% | ||
| MLCI - HSDT | 60% Loosely correlated | -1.25% | ||
| STKE - HSDT | 55% Loosely correlated | -3.02% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AMDY | 41.14 | 0.45 | +1.11% |
| YieldMax AMD Option Income Strategy ETF | |||
| GXPT | 31.03 | -0.39 | -1.24% |
| Global X PureCap MSCI Information Technology ETF (GXPT) | |||
| ICLN | 16.14 | -0.47 | -2.83% |
| iShares Global Clean Energy ETF (ICLN) | |||
| YGLD | 28.47 | -1.86 | -6.12% |
| Simplify Gold Strategy ETF (YGLD) | |||
| TXXD | 22.36 | -1.78 | -7.38% |
| 21Shares 2x Long Dogecoin ETF (TXXD) | |||